Blood Transfusion Access Guidelines

Primary Recommendations

For rapid blood transfusion in massive hemorrhage, large-bore peripheral access (≥8-French) is the ideal first choice, offering superior flow rates compared to standard central lines while avoiding central line complications 1, 2, 3, 4, 5
The American Society of Anesthesiologists recommends securing the largest bore peripheral or central access possible, with 8-French central access being ideal in adults 1, 2, 3, 4, 5

Attempt large-bore peripheral access (14-gauge or larger peripheral IV, or rapid infusion catheter) in patients with adequate peripheral veins 1, 2, 3, 4, 5
If peripheral access fails or is inadequate, proceed to 8-French central venous access (internal jugular or subclavian vein) 1, 2, 3, 4, 5
In extremis, consider intra-osseous or surgical venous access 1, 2, 3, 4, 5

In patients with stage 3b chronic kidney disease or greater (eGFR <45 mL/min), avoid inserting devices into arm veins to preserve vessels for potential hemodialysis access 6
Use peripheral IVs in the dorsum of the hand for short-term access (≤5 days) in patients with stage 3b chronic kidney disease or greater (eGFR <45 mL/min) 6
Consider tunneled small-bore central catheters in the jugular vein for longer durations in patients with stage 3b chronic kidney disease or greater (eGFR <45 mL/min) 6
A dedicated peripheral line is preferred in neonates to allow slow infusion rates and prevent infections 7
Catheter occlusion and hemolysis are potential risks with 24/28-gauge PICCs in extremely low gestational age neonates 7
Regardless of access type, rapid massive transfusion requires monitoring for hyperkalemia (particularly with rapid transfusions or irradiated/stored blood) 7
All transfused fluids must be actively warmed 1, 2, 3, 4, 5

Dedicated IV lines are required for whole‑blood transfusion to prevent incompatibility reactions, hemolysis, and clotting. [8][9]
For both massive hemorrhage and routine transfusion, a separate IV access should be used for all medications, distinct from the line used for blood products. [8][9]

Blood administration sets must incorporate integral mesh filters sized 170–200 µm; these filters are designed for blood components and can trap or interact with certain medications. 8
Leukocyte‑depletion filters and sub‑micrometre bacterial filters must not be used with specific blood products such as CAR‑T cell infusions, because mixing medications through these sets risks filter interaction. 9
All blood products should be actively warmed with approved warming devices before infusion. [8][10]
Standard blood administration sets equipped with 170–200 µm filters are recommended for routine transfusions. 8

Concurrent medication administration should be avoided during active transfusion; pre‑medication with paracetamol and antihistamine is given before transfusion, and corticosteroids are contraindicated during CAR‑T infusion. 9
No medication may be administered simultaneously with a blood product infusion. 9
If urgent medication is required and only one line is available, the transfusion should be temporarily paused, the line flushed with 0.9 % normal saline, the medication given, the line flushed again, and then the transfusion resumed. 8